HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2‐dependent manner

High mobility group nucleosome‐binding protein 3 (HMGN3), a member of the HMGN family, modulates the structure of chromatin and regulates transcription through transcription factors. HMGN3 has been implicated in the development of various cancers; however, the underlying mechanisms remain unclear. We herein demonstrated that the high expression of HMGN3 correlated with the metastasis of liver fluke infection‐induced cholangiocarcinoma (CCA) in patients in northeastern Thailand. The knockdown of HMGN3 in CCA cells significantly impaired the oncogenic properties of colony formation, migration, and invasion. HMGN3 inhibited the expression of and blocked the intracellular polarities of epithelial regulator genes, such as the CDH1/E‐cadherin and TJAP1 genes in CCA cells. A chromatin immunoprecipitation sequencing analysis revealed that HMGN3 required the transcription factor SNAI2 to bind to and repress the expression of epithelial regulator genes, at least in part, due to histone deacetylases (HDACs), the pharmacological inhibition of which reactivated these epithelial regulators in CCA, leading to impairing the cell migration capacity. Therefore, the overexpression of HMGN3 represses the transcription of and blocks the polarities of epithelial regulators in CCA cells in a manner that is dependent on the SNAI2 gene and HDACs.

[1]  Guojun Sheng.  Defining epithelial-mesenchymal transitions in animal development. , 2021, Development.

[2]  G. Gores,et al.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management , 2020, Nature Reviews Gastroenterology & Hepatology.

[3]  Raymond B. Runyan,et al.  Guidelines and definitions for research on epithelial–mesenchymal transition , 2020, Nature Reviews Molecular Cell Biology.

[4]  B. Teh,et al.  Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient , 2020, Human Cell.

[5]  T. Efferth,et al.  Chemoresistance and chemosensitization in cholangiocarcinoma. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[6]  Bin Tean Teh,et al.  Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. , 2017, Cancer discovery.

[7]  V. Paradis,et al.  Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. , 2017, Journal of hepatology.

[8]  R. Reeves.  High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells. , 2015, DNA repair.

[9]  A. Zhu.  Future directions in the treatment of cholangiocarcinoma. , 2015, Best practice & research. Clinical gastroenterology.

[10]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[11]  Nataliya Razumilava,et al.  Cholangiocarcinoma , 2014, The Lancet.

[12]  H. Saya,et al.  Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis , 2014, Tumor Biology.

[13]  Sharon Nofech-Mozes,et al.  Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. , 2014, Archives of pathology & laboratory medicine.

[14]  G. Gores,et al.  Pathogenesis, diagnosis, and management of cholangiocarcinoma. , 2013, Gastroenterology.

[15]  H. Fuchs,et al.  High Mobility Group N Proteins Modulate the Fidelity of the Cellular Transcriptional Profile in a Tissue- and Variant-specific Manner* , 2013, The Journal of Biological Chemistry.

[16]  Michael Bustin,et al.  Effects of HMGN variants on the cellular transcription profile , 2011, Nucleic acids research.

[17]  Dong-sheng Wang,et al.  The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma , 2010, Journal of experimental & clinical cancer research : CR.

[18]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[19]  M. Bustin.  High mobility group proteins. , 2010, Biochimica et biophysica acta.

[20]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[21]  M. Bustin,et al.  The Nucleosome Binding Protein HMGN3 Modulates the Transcription Profile of Pancreatic β Cells and Affects Insulin Secretion , 2009, Molecular and Cellular Biology.

[22]  Hyeon Je Cho,et al.  Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[23]  T. Rikiyama,et al.  Bile acids repress E‐cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma , 2008, Cancer science.

[24]  C. Pairojkul,et al.  Cholangiocarcinoma: lessons from Thailand , 2008, Current opinion in gastroenterology.

[25]  M. Bustin,et al.  HMG chromosomal proteins in development and disease. , 2007, Trends in cell biology.

[26]  M. Miwa,et al.  Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). , 2005, World journal of gastroenterology.

[27]  M. Bustin,et al.  Chromosomal Proteins HMGN3a and HMGN3b Regulate the Expression of Glycine Transporter 1 , 2004, Molecular and Cellular Biology.

[28]  D. Stolz,et al.  Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT , 2004, Transplantation.

[29]  Erik Schrumpf,et al.  Diagnosis and treatment of cholangiocarcinoma , 2004, Current gastroenterology reports.

[30]  E. Ballestar,et al.  Snail Mediates E-Cadherin Repression by the Recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex , 2004, Molecular and Cellular Biology.

[31]  Avri Ben-Ze'ev,et al.  Autoregulation of E-cadherin expression by cadherin–cadherin interactions , 2003, The Journal of cell biology.

[32]  M. Fraga,et al.  The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2003, Journal of Cell Science.

[33]  M. Bustin,et al.  HMGN3a and HMGN3b, Two Protein Isoforms with a Tissue-specific Expression Pattern, Expand the Cellular Repertoire of Nucleosome-binding Proteins* , 2001, The Journal of Biological Chemistry.

[34]  M. Bustin.  Chromatin unfolding and activation by HMGN(*) chromosomal proteins. , 2001, Trends in biochemical sciences.